drugset / Trial / NCT04237103

Combination of Methotrexate and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo

NCT04237103 ↗

Phase 2 Completed 32 enrolled University Hospital, Bordeaux
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a phase 2, randomized, double blind, multicenter study evaluating the efficacy and safety of the combination of methotrexate plus UVB TL01 in vitiligo.

Timeline

Start
2023-05-23
Primary completion
2025-11-04
Completion
2025-11-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Methotrexate Small molecule — Oral

Indications